Literature DB >> 2182021

L-NG-monomethyl arginine inhibits the vasodilating effects of low dose of endothelin-3 on rat mesenteric arteries.

N Fukuda1, Y Izumi, M Soma, Y Watanabe, M Watanabe, M Hatano, I Sakuma, H Yasuda.   

Abstract

We have reported that low doses of endothelin-3 (ET-3) elicited continuous vasodilation of rat mesenteric arteries, which is possibly related to endothelium-derived relaxing factor (EDRF). In order to clarify whether or not the vasodilating effects of ET-3 are associated with EDRF, we examined the effects of L-NG-monomethyl arginine (L-NMMA), an analog of L-arginine, on low-dose ET-3 induced vasodilation of rat mesente-Hc arteries. Infusion of 50 microM L-NMMA inhibited the vasodilation induced by 10(-13) M ET-3 and rather elicited an increase in perfusion pressure, which itself was decreased by infusion of 150 microM L-arginine. In the presence of 50 microM L-NMMA, 10(-13) M ET-3 did not elicit any vasodilation of the mesenteric arteries preconstricted with NE, in which 150 microM L-arginine, but not D-arginine, caused considerable vasodilation. These data suggest that the vasodilating effects of low doses of ET-3 are associated with EDRF as an endothelium-derived nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182021     DOI: 10.1016/0006-291x(90)92087-g

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Regional differences in the density and subtype specificity of endothelin receptors in rabbit urinary tract.

Authors:  J Latifpour; Y Fukumoto; R M Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

2.  Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis.

Authors:  W A Bax; A T Bruinvels; R J van Suylen; P R Saxena; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

3.  Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

5.  Mechanisms of the biphasic responses to endothelin-3 in dog coronary arteries.

Authors:  T Okamura; T Matsumoto; F Ikemoto; N Toda
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

6.  Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.

Authors:  E G McMahon; M A Palomo; W M Moore; J F McDonald; M K Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

7.  Endothelin signaling pathways in rat adrenal medulla.

Authors:  Israel Anita; Mathison Yaira; Garrido María del Rosario
Journal:  Cell Mol Neurobiol       Date:  2006-08-09       Impact factor: 5.046

8.  Endothelin (ET)-3 stimulates cyclic guanosine 3',5'-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells.

Authors:  A Owada; K Tomita; Y Terada; H Sakamoto; H Nonoguchi; F Marumo
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

9.  SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.

Authors:  Lei L Chen; Jing Zhu; Jonathan Schumacher; Chongjuan Wei; Latha Ramdas; Victor G Prieto; Arnie Jimenez; Marco A Velasco; Sheryl R Tripp; Robert H I Andtbacka; Launce Gouw; George M Rodgers; Liansheng Zhang; Benjamin K Chan; Pamela B Cassidy; Robert S Benjamin; Sancy A Leachman; Marsha L Frazier
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.